High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS)
Abstract C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data are available on high-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of PCOS especially in Indian women....
Saved in:
Published in | Gynecological endocrinology Vol. 30; no. 11; pp. 781 - 784 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Informa UK Ltd
01.11.2014
Taylor & Francis |
Subjects | |
Online Access | Get full text |
ISSN | 0951-3590 1473-0766 1473-0766 |
DOI | 10.3109/09513590.2014.924099 |
Cover
Abstract | Abstract
C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data are available on high-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of PCOS especially in Indian women. The objective was to determine serum hs-CRP concentration in adolescent women with and without PCOS and to assess possible correlations of serum hs-CRP levels with components of PCOS in Indian women. One hundred and sixty women with PCOS and sixty non-PCOS women having normal menstrual cycles were included. Clinical assessment included anthropometry, Ferriman-Gallwey (FG) score and blood pressure (BP) measurement. Laboratory evaluation included estimation of T4, TSH, LH, FSH, total testosterone, prolactin, cortisol, 17OHP, hs-CRP, lipid profile, and insulin, and glucose after 2-h oral glucose tolerance test. Homeostasis Model Assessment Insulin resistance index (HOMA-IR) and Quantitative Insulin Sensitivity Check Index (QUICKI) and glucose intolerance was calculated. FG score, LH, FSH, total Testosterone, HOMA-IR and QUICKI were significantly different among women with or without PCOS (p < 0.01). Although hs-CRP levels showed a higher trend in women having PCOS, there was no significant difference between the groups (p > 0.05). A significant and positive correlation was found between hs-CRP and body mass index (BMI) (r = 0.308, p < 0.01) among PCOS group. The results in Indian adolescent women suggest that hs-CRP levels may not per se be associated with PCOS, rather can be related to fat mass in this subset of subjects.
Chinese abstract
C反应蛋白(CRP)是2型糖尿病和心血管疾病的危险因素。对于多囊卵巢综合征(PCOS),尤其是印度女性,在高敏C反应蛋白(hs-CRP)水平及其与PCOS的各项组分的关系方面,可查到的数据很有限。本研究的目的是监测患或不患PCOS的青春期女性的血清hs-CRP浓度,评估印度女性的血清hs-CRP浓度与PCOS指标间可能的相关性。160名PCOS患者和60名有正常月经周期的非PCOS女性参与了本试验。临床评价包括人体测量,Ferriman-Gallwey(FG)评分和血压(BP)测量。实验室测定指标包括T4,TSH, LH,,FSH,总睾酮,催乳素,皮质醇,17-OHP,hs-CRP,血脂,胰岛素的测量和2h口服葡萄糖耐量试验。同时测量稳态模式评估胰岛素抵抗指数(HOMA-IR),定量胰岛素敏感性检测指数(QUICKI)以及葡萄糖耐量。PCOS患者与正常女性的FG得分,LH,,FSH,HOMA-IR,QUICKI存在显著不同(p<0.01),尽管PCOS患者的hs-CRP水平有增高的趋势,但两组并无显著差别(p>0.05)。在PCOS组还发现hs-CRP与体重指数(BMI)有显著正相关(r=0.308, p<0.01)。该结果表明,hs-CRP水平与PCOS也许无关联性,而可能与该课题中的子项目即体重相关。 |
---|---|
AbstractList | C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data are available on high-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of PCOS especially in Indian women. The objective was to determine serum hs-CRP concentration in adolescent women with and without PCOS and to assess possible correlations of serum hs-CRP levels with components of PCOS in Indian women. One hundred and sixty women with PCOS and sixty non-PCOS women having normal menstrual cycles were included. Clinical assessment included anthropometry, Ferriman-Gallwey (FG) score and blood pressure (BP) measurement. Laboratory evaluation included estimation of T4, TSH, LH, FSH, total testosterone, prolactin, cortisol, 17OHP, hs-CRP, lipid profile, and insulin, and glucose after 2-h oral glucose tolerance test. Homeostasis Model Assessment Insulin resistance index (HOMA-IR) and Quantitative Insulin Sensitivity Check Index (QUICKI) and glucose intolerance was calculated. FG score, LH, FSH, total Testosterone, HOMA-IR and QUICKI were significantly different among women with or without PCOS (p < 0.01). Although hs-CRP levels showed a higher trend in women having PCOS, there was no significant difference between the groups (p > 0.05). A significant and positive correlation was found between hs-CRP and body mass index (BMI) (r = 0.308, p < 0.01) among PCOS group. The results in Indian adolescent women suggest that hs-CRP levels may not per se be associated with PCOS, rather can be related to fat mass in this subset of subjects.
C反应蛋白(CRP)是2型糖尿病和心血管疾病的危险因素。对于多囊卵巢综合征(PCOS),尤其是印度女性,在高敏C反应蛋白(hs-CRP)水平及其与PCOS的各项组分的关系方面,可查到的数据很有限。本研究的目的是监测患或不患PCOS的青春期女性的血清hs-CRP浓度,评估印度女性的血清hs-CRP浓度与PCOS指标间可能的相关性。160名PCOS患者和60名有正常月经周期的非PCOS女性参与了本试验。临床评价包括人体测量,Ferriman-Gallwey(FG)评分和血压(BP)测量。实验室测定指标包括T4,TSH, LH,,FSH,总睾酮,催乳素,皮质醇,17-OHP,hs-CRP,血脂,胰岛素的测量和2h口服葡萄糖耐量试验。同时测量稳态模式评估胰岛素抵抗指数(HOMA-IR),定量胰岛素敏感性检测指数(QUICKI)以及葡萄糖耐量。PCOS患者与正常女性的FG得分,LH,,FSH,HOMA-IR,QUICKI存在显著不同(p<0.01),尽管PCOS患者的hs-CRP水平有增高的趋势,但两组并无显著差别(p>0.05)。在PCOS组还发现hs-CRP与体重指数(BMI)有显著正相关(r=0.308, p<0.01)。该结果表明,hs-CRP水平与PCOS也许无关联性,而可能与该课题中的子项目即体重相关。 C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data are available on high-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of PCOS especially in Indian women. The objective was to determine serum hs-CRP concentration in adolescent women with and without PCOS and to assess possible correlations of serum hs-CRP levels with components of PCOS in Indian women. One hundred and sixty women with PCOS and sixty non-PCOS women having normal menstrual cycles were included. Clinical assessment included anthropometry, Ferriman-Gallwey (FG) score and blood pressure (BP) measurement. Laboratory evaluation included estimation of T4, TSH, LH, FSH, total testosterone, prolactin, cortisol, 17OHP, hs-CRP, lipid profile, and insulin, and glucose after 2-h oral glucose tolerance test. Homeostasis Model Assessment Insulin resistance index (HOMA-IR) and Quantitative Insulin Sensitivity Check Index (QUICKI) and glucose intolerance was calculated. FG score, LH, FSH, total Testosterone, HOMA-IR and QUICKI were significantly different among women with or without PCOS (p < 0.01). Although hs-CRP levels showed a higher trend in women having PCOS, there was no significant difference between the groups (p > 0.05). A significant and positive correlation was found between hs-CRP and body mass index (BMI) (r = 0.308, p < 0.01) among PCOS group. The results in Indian adolescent women suggest that hs-CRP levels may not per se be associated with PCOS, rather can be related to fat mass in this subset of subjects.C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data are available on high-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of PCOS especially in Indian women. The objective was to determine serum hs-CRP concentration in adolescent women with and without PCOS and to assess possible correlations of serum hs-CRP levels with components of PCOS in Indian women. One hundred and sixty women with PCOS and sixty non-PCOS women having normal menstrual cycles were included. Clinical assessment included anthropometry, Ferriman-Gallwey (FG) score and blood pressure (BP) measurement. Laboratory evaluation included estimation of T4, TSH, LH, FSH, total testosterone, prolactin, cortisol, 17OHP, hs-CRP, lipid profile, and insulin, and glucose after 2-h oral glucose tolerance test. Homeostasis Model Assessment Insulin resistance index (HOMA-IR) and Quantitative Insulin Sensitivity Check Index (QUICKI) and glucose intolerance was calculated. FG score, LH, FSH, total Testosterone, HOMA-IR and QUICKI were significantly different among women with or without PCOS (p < 0.01). Although hs-CRP levels showed a higher trend in women having PCOS, there was no significant difference between the groups (p > 0.05). A significant and positive correlation was found between hs-CRP and body mass index (BMI) (r = 0.308, p < 0.01) among PCOS group. The results in Indian adolescent women suggest that hs-CRP levels may not per se be associated with PCOS, rather can be related to fat mass in this subset of subjects. C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data are available on high-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of PCOS especially in Indian women. The objective was to determine serum hs-CRP concentration in adolescent women with and without PCOS and to assess possible correlations of serum hs-CRP levels with components of PCOS in Indian women. One hundred and sixty women with PCOS and sixty non-PCOS women having normal menstrual cycles were included. Clinical assessment included anthropometry, Ferriman-Gallwey (FG) score and blood pressure (BP) measurement. Laboratory evaluation included estimation of T4, TSH, LH, FSH, total testosterone, prolactin, cortisol, 17OHP, hs-CRP, lipid profile, and insulin, and glucose after 2-h oral glucose tolerance test. Homeostasis Model Assessment Insulin resistance index (HOMA-IR) and Quantitative Insulin Sensitivity Check Index (QUICKI) and glucose intolerance was calculated. FG score, LH, FSH, total Testosterone, HOMA-IR and QUICKI were significantly different among women with or without PCOS (p < 0.01). Although hs-CRP levels showed a higher trend in women having PCOS, there was no significant difference between the groups (p > 0.05). A significant and positive correlation was found between hs-CRP and body mass index (BMI) (r = 0.308, p < 0.01) among PCOS group. The results in Indian adolescent women suggest that hs-CRP levels may not per se be associated with PCOS, rather can be related to fat mass in this subset of subjects. Abstract C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data are available on high-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of PCOS especially in Indian women. The objective was to determine serum hs-CRP concentration in adolescent women with and without PCOS and to assess possible correlations of serum hs-CRP levels with components of PCOS in Indian women. One hundred and sixty women with PCOS and sixty non-PCOS women having normal menstrual cycles were included. Clinical assessment included anthropometry, Ferriman-Gallwey (FG) score and blood pressure (BP) measurement. Laboratory evaluation included estimation of T4, TSH, LH, FSH, total testosterone, prolactin, cortisol, 17OHP, hs-CRP, lipid profile, and insulin, and glucose after 2-h oral glucose tolerance test. Homeostasis Model Assessment Insulin resistance index (HOMA-IR) and Quantitative Insulin Sensitivity Check Index (QUICKI) and glucose intolerance was calculated. FG score, LH, FSH, total Testosterone, HOMA-IR and QUICKI were significantly different among women with or without PCOS (p < 0.01). Although hs-CRP levels showed a higher trend in women having PCOS, there was no significant difference between the groups (p > 0.05). A significant and positive correlation was found between hs-CRP and body mass index (BMI) (r = 0.308, p < 0.01) among PCOS group. The results in Indian adolescent women suggest that hs-CRP levels may not per se be associated with PCOS, rather can be related to fat mass in this subset of subjects. Chinese abstract C反应蛋白(CRP)是2型糖尿病和心血管疾病的危险因素。对于多囊卵巢综合征(PCOS),尤其是印度女性,在高敏C反应蛋白(hs-CRP)水平及其与PCOS的各项组分的关系方面,可查到的数据很有限。本研究的目的是监测患或不患PCOS的青春期女性的血清hs-CRP浓度,评估印度女性的血清hs-CRP浓度与PCOS指标间可能的相关性。160名PCOS患者和60名有正常月经周期的非PCOS女性参与了本试验。临床评价包括人体测量,Ferriman-Gallwey(FG)评分和血压(BP)测量。实验室测定指标包括T4,TSH, LH,,FSH,总睾酮,催乳素,皮质醇,17-OHP,hs-CRP,血脂,胰岛素的测量和2h口服葡萄糖耐量试验。同时测量稳态模式评估胰岛素抵抗指数(HOMA-IR),定量胰岛素敏感性检测指数(QUICKI)以及葡萄糖耐量。PCOS患者与正常女性的FG得分,LH,,FSH,HOMA-IR,QUICKI存在显著不同(p<0.01),尽管PCOS患者的hs-CRP水平有增高的趋势,但两组并无显著差别(p>0.05)。在PCOS组还发现hs-CRP与体重指数(BMI)有显著正相关(r=0.308, p<0.01)。该结果表明,hs-CRP水平与PCOS也许无关联性,而可能与该课题中的子项目即体重相关。 |
Author | Douhat, Syed Nisar, Sobia Rashid, Aafia Ahmed, Ishfaq Mudassar, Syed Ganie, Mohd Ashraf Jan, Vicar M. Rashid, Fouzia Shamas, Nasir Hassan, Saqib |
Author_xml | – sequence: 1 givenname: Mohd Ashraf surname: Ganie fullname: Ganie, Mohd Ashraf email: ashraf.endo@gmail.com, ashraf.endo@gmail.com organization: Department of Endocrinology and Metabolism, All India Institute of Medical Sciences – sequence: 2 givenname: Saqib surname: Hassan fullname: Hassan, Saqib email: ashraf.endo@gmail.com, ashraf.endo@gmail.com organization: Department of Endocrinology, Sheri-Kashmir Institute of Medical Sciences – sequence: 3 givenname: Sobia surname: Nisar fullname: Nisar, Sobia email: ashraf.endo@gmail.com, ashraf.endo@gmail.com organization: Departments of Geriatric Medicine, All India of Medical Sciences – sequence: 4 givenname: Nasir surname: Shamas fullname: Shamas, Nasir email: ashraf.endo@gmail.com, ashraf.endo@gmail.com organization: Department of Endocrinology, Sheri-Kashmir Institute of Medical Sciences – sequence: 5 givenname: Aafia surname: Rashid fullname: Rashid, Aafia email: ashraf.endo@gmail.com, ashraf.endo@gmail.com organization: Department of Endocrinology, Sheri-Kashmir Institute of Medical Sciences – sequence: 6 givenname: Ishfaq surname: Ahmed fullname: Ahmed, Ishfaq email: ashraf.endo@gmail.com, ashraf.endo@gmail.com organization: Department of Endocrinology, Sheri-Kashmir Institute of Medical Sciences – sequence: 7 givenname: Syed surname: Douhat fullname: Douhat, Syed email: ashraf.endo@gmail.com, ashraf.endo@gmail.com organization: Department of Endocrinology, Sheri-Kashmir Institute of Medical Sciences – sequence: 8 givenname: Syed surname: Mudassar fullname: Mudassar, Syed email: ashraf.endo@gmail.com, ashraf.endo@gmail.com organization: Department of Clinical Biochemistry, Sheri-Kashmir Institute of Medical Sciences – sequence: 9 givenname: Vicar M. surname: Jan fullname: Jan, Vicar M. email: ashraf.endo@gmail.com, ashraf.endo@gmail.com organization: Department of Cardiology, Sheri-Kashmir Institute of Medical Sciences – sequence: 10 givenname: Fouzia surname: Rashid fullname: Rashid, Fouzia email: ashraf.endo@gmail.com, ashraf.endo@gmail.com organization: Department of Clinical Biochemistry, University of Kashmir |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25137507$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1u1DAUhS1URKeFN0DIy-kigx07icMChCJKK1Vqxc_aupM4xJVjB9szo7wYz1cP01mARFlZV_d8R9fnnKET66xC6DUlK0ZJ_ZbUBWVFTVY5oXxV55zU9TO0oLxiGanK8gQt9pJsrzlFZyHcE0IZr_IX6DRPaFWQaoF-XekfQxaUDTrqrY4zbjKvoE2DwpN3UWmLl0PImi93F9iorTIBg-2wjgF7ZSBqZ8OgJ7zTccCtG6d0pk1L1-PJmbmdQ9QtdlvwMw6z7bwbFU6m17bTYDF0zqjQJgTv0sYefP5NLu-a268XL9HzHkxQrx7fc_T98tO35iq7uf183Xy8yVpORcygE3nB1n0vWMfKdVmmoRAgGEm_F1D0gpeEsIJCLghjnOTAAARdcybqvOLsHC0PvimKnxsVohx1OtYYsMptgqQlLXlVUSaS9M2jdLMeVScnr8d0uTxmnQTvDoLWuxC86mWr4-_8ogdtJCVyX6w8Fiv3xcpDsQnmf8FH__9gHw6Ytr3zI-ycN52MMBvnew-21WFPP-nw_g-HQYGJQwteyXu38Tal__QJD4Ppzsc |
CitedBy_id | crossref_primary_10_1016_j_fertnstert_2020_02_001 crossref_primary_10_1097_MD_0000000000032326 crossref_primary_10_3390_biomedicines11071953 crossref_primary_10_1016_j_fertnstert_2015_09_005 crossref_primary_10_1002_edm2_477 crossref_primary_10_21763_tjfmpc_359835 crossref_primary_10_1007_s40618_016_0582_x crossref_primary_10_1038_s41598_019_40653_z crossref_primary_10_1007_s12291_023_01115_6 crossref_primary_10_20945_2359_3997000000497 crossref_primary_10_1002_ijgo_13125 crossref_primary_10_3109_09513590_2016_1141879 crossref_primary_10_1016_j_psj_2023_102820 crossref_primary_10_31832_smj_855493 crossref_primary_10_2217_bmm_2018_0271 crossref_primary_10_1177_2050313X19843737 crossref_primary_10_1007_s43032_021_00662_8 crossref_primary_10_2147_JIR_S313193 crossref_primary_10_1016_j_jpag_2016_03_004 |
Cites_doi | 10.2337/dc08-1795 10.1210/jc.2007-0334 10.1161/01.CIR.102.1.42 10.1016/j.jpag.2011.03.002 10.1210/jc.2003-031096 10.1210/jcem.86.6.7580 10.1093/clinchem/36.2.283 10.1530/eje.0.1500525 10.1093/humupd/dmr025 10.1155/2009/465203 10.2337/diab.38.9.1165 10.1186/1741-7015-8-41 10.1016/S0002-9378(15)30642-6 10.1016/j.mce.2010.08.002 10.1080/09513590701554306 10.1056/NEJM200003233421202 10.1161/01.CIR.0000089191.72957.ED 10.1093/humupd/dmg044 10.3109/09513590.2011.613967 10.1530/EJE-09-0379 10.1210/jc.2009-2724 10.1210/jc.2006-0178 10.1161/01.CIR.0000053730.47739.3C 10.1038/nrendo.2010.217 10.3904/kjim.2009.24.4.350 10.1210/jc.2003-032046 10.4103/2230-8210.95680 10.4103/2230-8210.103021 |
ContentType | Journal Article |
Copyright | 2014 Informa UK Ltd. All rights reserved: reproduction in whole or part not permitted 2014 |
Copyright_xml | – notice: 2014 Informa UK Ltd. All rights reserved: reproduction in whole or part not permitted 2014 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.3109/09513590.2014.924099 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1473-0766 |
EndPage | 784 |
ExternalDocumentID | 25137507 10_3109_09513590_2014_924099 924099 |
Genre | Research Article Journal Article Observational Study |
GeographicLocations | India |
GeographicLocations_xml | – name: India |
GroupedDBID | --- 00X 03L 0BK 0R~ 0YH 29I 36B 3V. 4.4 53G 5GY 5VS 7X7 88E 8AO 8FI 8FJ AAJNR AALIY AALUX AAMIU AAPUL AAPXX AAQRR ABBKH ABDBF ABEIZ ABLKL ABPTK ABUPF ABUWG ABWCV ABZEW ACENM ACFUF ACGEJ ACGFO ACGFS ACKZS ACLSK ADBBV ADCVX ADFCX ADFOM ADFZZ ADRBQ ADXPE AECIN AEGXH AEIIZ AENEX AEOZL AEYQI AFKRA AFKVX AFLEI AFWLO AGDLA AGFJD AGRBW AHMBA AIAGR AIJEM AIRBT AJVHN AJWEG AKBVH ALIIL ALMA_UNASSIGNED_HOLDINGS ALQZU AMDAE AWYRJ BABNJ BENPR BLEHA BOHLJ BPHCQ BRMBE BVXVI CAG CCCUG COF CS3 CYYVM CZDIS DKSSO DRXRE DU5 DWTOO EAP EBC EBD EBS EJD EMB EMK EMOBN EPL ESX F5P FYUFA H13 HZ~ IPNFZ JENTW KRBQP KSSTO KWAYT KYCEM LGLTD LJTGL M1P M44 M4Z O9- P2P PQEST PQQKQ PQUKI PROAC PSQYO QQXMO RIG RNANH RRB RVRKI RWL S0X SV3 TAE TFDNU TFL TFW TUS UEQFS UKHRP V1S ~1N ABJNI ABLIJ ABXYU ACUHS AGYJP ALIPV ALYBC TBQAZ TDBHL TERGH TUROJ AAFWJ AAGDL AAORF AAYXX ABWVI ACOPL ACYZI ADYSH AFPKN AFRVT CCPQU CITATION GROUPED_DOAJ HMCUK NUSFT PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c418t-ad8253bff83d36b6653b58a8307508a5f84600351a28033402a3aa81b43892743 |
ISSN | 0951-3590 1473-0766 |
IngestDate | Thu Sep 04 17:21:02 EDT 2025 Thu Apr 03 07:01:25 EDT 2025 Thu Apr 24 23:01:24 EDT 2025 Tue Jul 01 00:23:11 EDT 2025 Wed Dec 25 09:04:53 EST 2024 Wed Jun 21 08:14:53 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Body mass index HOMA-IR hs C-reactive protein testosterone insulin resistance Ferriman–Gallwey score obesity polycystic ovary syndrome |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c418t-ad8253bff83d36b6653b58a8307508a5f84600351a28033402a3aa81b43892743 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
PMID | 25137507 |
PQID | 1616477138 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | crossref_citationtrail_10_3109_09513590_2014_924099 crossref_primary_10_3109_09513590_2014_924099 informaworld_taylorfrancis_310_3109_09513590_2014_924099 proquest_miscellaneous_1616477138 pubmed_primary_25137507 informahealthcare_journals_10_3109_09513590_2014_924099 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20141100 11/1/2014 2014-11-00 2014-Nov 20141101 |
PublicationDateYYYYMMDD | 2014-11-01 |
PublicationDate_xml | – month: 11 year: 2014 text: 20141100 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Gynecological endocrinology |
PublicationTitleAlternate | Gynecol Endocrinol |
PublicationYear | 2014 |
Publisher | Informa UK Ltd Taylor & Francis |
Publisher_xml | – name: Informa UK Ltd – name: Taylor & Francis |
References | Oh JY (CIT0021) 2009; 24 Gill H (CIT0003) 2012; 16 CIT0012 Capoglu I (CIT0023) 2009; 4 Boulman N (CIT0016) 2004; 89 Tosi F (CIT0025) 2009; 161 Azziz R (CIT0001) 2004; 89 Guzelmeric K (CIT0019) 2007; 23 Dunaif A (CIT0011) 1989; 38 Azziz R (CIT0026) 2006; 91 CIT0018 CIT0017 Festa A (CIT0028) 2000; 102 Balen AH (CIT0027) 2003; 9 Ferrannini E (CIT0029) 2007; 92 Ridker PM (CIT0013) 2000; 342 Wild RA (CIT0010) 1990; 36 CIT0020 de Rooij SR (CIT0030) 2009; 32 Teede H (CIT0007) 2010; 8 Verma S (CIT0015) 2003; 108 Kim JW (CIT0024) 2012; 28 Ridker PM (CIT0014) 2003; 107 Legro RS (CIT0005) 1999; 84 CIT0002 CIT0004 CIT0006 CIT0009 CIT0008 Karoli R (CIT0022) 2012; 16 |
References_xml | – volume: 32 start-page: 1295 year: 2009 ident: CIT0030 publication-title: Diabetes Care doi: 10.2337/dc08-1795 – volume: 92 start-page: 2885 year: 2007 ident: CIT0029 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2007-0334 – volume: 102 start-page: 42 year: 2000 ident: CIT0028 publication-title: Circulation doi: 10.1161/01.CIR.102.1.42 – ident: CIT0002 doi: 10.1016/j.jpag.2011.03.002 – volume: 89 start-page: 2160 year: 2004 ident: CIT0016 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-031096 – ident: CIT0012 doi: 10.1210/jcem.86.6.7580 – volume: 36 start-page: 283 year: 1990 ident: CIT0010 publication-title: Clin Chem doi: 10.1093/clinchem/36.2.283 – ident: CIT0017 doi: 10.1530/eje.0.1500525 – ident: CIT0020 doi: 10.1093/humupd/dmr025 – ident: CIT0018 doi: 10.1155/2009/465203 – volume: 38 start-page: 1165 year: 1989 ident: CIT0011 publication-title: Diabetes doi: 10.2337/diab.38.9.1165 – volume: 8 start-page: 41 year: 2010 ident: CIT0007 publication-title: BMC Med doi: 10.1186/1741-7015-8-41 – ident: CIT0006 doi: 10.1016/S0002-9378(15)30642-6 – ident: CIT0009 doi: 10.1016/j.mce.2010.08.002 – volume: 23 start-page: 505 year: 2007 ident: CIT0019 publication-title: Gynecol Endocrinol doi: 10.1080/09513590701554306 – volume: 84 start-page: 165 year: 1999 ident: CIT0005 publication-title: J Clin Endocrinol Metab – volume: 342 start-page: 836 year: 2000 ident: CIT0013 publication-title: N Engl J Med doi: 10.1056/NEJM200003233421202 – volume: 108 start-page: 2054 year: 2003 ident: CIT0015 publication-title: Circulation doi: 10.1161/01.CIR.0000089191.72957.ED – volume: 9 start-page: 505 year: 2003 ident: CIT0027 publication-title: Hum Reprod Update doi: 10.1093/humupd/dmg044 – volume: 28 start-page: 259 year: 2012 ident: CIT0024 publication-title: Gynecol Endocrinol doi: 10.3109/09513590.2011.613967 – volume: 161 start-page: 737 year: 2009 ident: CIT0025 publication-title: Eur J Endocrinol doi: 10.1530/EJE-09-0379 – ident: CIT0008 doi: 10.1210/jc.2009-2724 – volume: 91 start-page: 4237 year: 2006 ident: CIT0026 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2006-0178 – volume: 4 start-page: 428 year: 2009 ident: CIT0023 publication-title: Cent Eur J Med – volume: 107 start-page: 363 year: 2003 ident: CIT0014 publication-title: Circulation doi: 10.1161/01.CIR.0000053730.47739.3C – ident: CIT0004 doi: 10.1038/nrendo.2010.217 – volume: 24 start-page: 350 year: 2009 ident: CIT0021 publication-title: Korean J Intern Med doi: 10.3904/kjim.2009.24.4.350 – volume: 89 start-page: 2745 year: 2004 ident: CIT0001 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-032046 – volume: 16 start-page: 389 year: 2012 ident: CIT0003 publication-title: Indian J Endocr Metab doi: 10.4103/2230-8210.95680 – volume: 16 start-page: 1004 year: 2012 ident: CIT0022 publication-title: Indian J Endocrinol Metab doi: 10.4103/2230-8210.103021 |
SSID | ssj0013472 |
Score | 2.168394 |
Snippet | Abstract
C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data... C-reactive protein (CRP) is a risk marker for type 2 diabetes mellitus and cardiovascular diseases. In polycystic ovary syndrome (PCOS), limited data are... |
SourceID | proquest pubmed crossref informaworld informahealthcare |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 781 |
SubjectTerms | Adolescent Adult Blood Glucose - metabolism Body Mass Index C-Reactive Protein - metabolism Cardiovascular Diseases - blood Cardiovascular Diseases - etiology Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - etiology Female Ferriman-Gallwey score Follicle Stimulating Hormone - blood Glucose Tolerance Test HOMA-IR hs C-reactive protein Humans India Insulin - blood insulin resistance Insulin Resistance - physiology Lipids - blood Luteinizing Hormone - blood obesity Obesity - blood polycystic ovary syndrome Polycystic Ovary Syndrome - blood Polycystic Ovary Syndrome - complications Risk Factors testosterone Testosterone - blood Thyroid Hormones - blood Young Adult |
Title | High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS) |
URI | https://www.tandfonline.com/doi/abs/10.3109/09513590.2014.924099 https://www.ncbi.nlm.nih.gov/pubmed/25137507 https://www.proquest.com/docview/1616477138 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FVkJcUHk2vLRIHFpVW2zv-pFjG2gLEqUirdSbtV7bSqTUDnGCFH4Yf44LM971I6FpKRcrsbLjx3yZnZn9doaQd17qutJOXZZwzplQImI9J4lYYsfKs5TqKV3t89Q7uRCfL93LTud3i7U0n0X76ue1-0r-R6twDvSKu2TvoNlaKJyAz6BfOIKG4fhPOkaSBiuQgm56QPQZ-IClBdsrCzCMULXBsGD9b2cY_4-RIlS0FgwMEw4ZW4aEfjXJs8RwYyb5eKEWWMl5L_-B9LqqvgFmST5lZVWDpiSUruag5awfCfdz1v86qDIQxi8-XmSJqu1wksU5WLPllP8xboYv87f5MAZYDacybexnUZhMrvw-ilqLLZo_PsijUT3_DIbySm9jO5XFaNrOe9jCbABsJzBtxl3dbHQ_0eZb-JxZvu7jUtl3s-5jcGy3rLWvu8WYid_XvepW5xSuS7Li5fBqyAYU-xC1Wrqx03IJ75WptSY8QqiFcsJKSohSQi3lHtl0fB85BpsHhx8Oj5pFMFH2HqsfVO_8RDnvr7ubJc9qy9TdHdYswpVavOsjqtKzOt8iD01IRA80vh-RTpI9Jve_GNLHE_JrFea0gTk1MKc7GuS7VEOcAsQpQJy2IU4RmrSBOM1T2gCVlkClFVApCNUQpw3EaQlxLWf9yB0E-O5TcnH08bx_wky7EaaEHcyYjAPH5VGaBjzmXuR58MUNZMDRqw6km4KrXi68S-zoxoXlSC4lhH0CnH4HPPFnZCOD-98mNHUs1bOEnaZuLGK7F1lClb6061pp7CVdwitVhcrU4seWMOPwJqB0CatHTXQtmlt-7_-FgtCYr-KWkUEbK-GszB6mutUPDrtp6NsKVyHMVLj8KLMkn8MFPaxd6Ns86JLnGnD1Y0CUxeEt-y_u-IgvyYPGNrwiG7PpPHkNUcIsemP-TX8A79kNhg |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High-sensitivity+C-reactive+protein+%28hs-CRP%29+levels+and+its+relationship+with+components+of+polycystic+ovary+syndrome+in+Indian+adolescent+women+with+polycystic+ovary+syndrome+%28PCOS%29&rft.jtitle=Gynecological+endocrinology&rft.au=Ganie%2C+Mohd+Ashraf&rft.au=Hassan%2C+Saqib&rft.au=Nisar%2C+Sobia&rft.au=Shamas%2C+Nasir&rft.date=2014-11-01&rft.issn=0951-3590&rft.eissn=1473-0766&rft.volume=30&rft.issue=11&rft.spage=781&rft.epage=784&rft_id=info:doi/10.3109%2F09513590.2014.924099&rft.externalDBID=n%2Fa&rft.externalDocID=10_3109_09513590_2014_924099 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0951-3590&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0951-3590&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0951-3590&client=summon |